When available this is likely to be a high profile paper, as this journal is top-ranked.
For reference, Nature is 69.5 and Cell is 66.9 (Nature's Molecular Psychiatry is 13.4).
An editorial in the most recent issue of World Psychiatry is Understanding depression beyond the “mind-body” dichotomy which starts off with —
"Do people in these regions just “somatize” what is primarily a “psychological” experience?" Unlikely. Either the diagnosis of depression in those regions is inaccurate and inappropriately broad or the disease understanding in the other regions is incomplete/naive.
Continues with unnecessarily gendered language, while blaming the patient —
---
Some alternative references —
A mitochondrial nexus in major depressive disorder: Integration with the psycho-immune-neuroendocrine network (2024, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease)
Association between mitochondrial DNA levels and depression: a systematic review and meta-analysis (2023, BMC Psychiatry)
Mitochondrial dysfunction: A fatal blow in depression (2023, Biomedicine & Pharmacotherapy)
Connecting Dots between Mitochondrial Dysfunction and Depression (2023, Biomolecules)
Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders (2019, Antioxidants & Redox Signaling)
Wikipedia said:According to the Journal Citation Reports, the journal has a 2022 impact factor of 73.3. It is ranked no. 1 out of 155 journals in the category Psychiatry and no. 1 out of 144 journals in the Social Sciences Citation Index category.
For reference, Nature is 69.5 and Cell is 66.9 (Nature's Molecular Psychiatry is 13.4).
An editorial in the most recent issue of World Psychiatry is Understanding depression beyond the “mind-body” dichotomy which starts off with —
In both the ICD-11 and the DSM-5, the core symptoms of depression are reported to be depressed mood (e.g., feeling sad, down or hopeless) and markedly diminished interest or pleasure in activities. However, in the ICD-10 diagnostic guidelines, a third core symptom was also identified: “fatigue or low energy”. In two regions of the world (Latin America and East Asia), “fatigue” is the most commonly experienced depressive symptom1. In a third region (Southeast Asia), “issues with the heart” are the most commonly reported depressive symptoms, along with depressed mood1. Do people in these regions just “somatize” what is primarily a “psychological” experience? Do “somatic” symptoms just represent a “mask”, as implied some decades ago by the concept of “masked depression”2?
"Do people in these regions just “somatize” what is primarily a “psychological” experience?" Unlikely. Either the diagnosis of depression in those regions is inaccurate and inappropriately broad or the disease understanding in the other regions is incomplete/naive.
Continues with unnecessarily gendered language, while blaming the patient —
The way these core phenomena are perceived, elaborated and verbalized by the affected person likely depends upon how that person generally functions and appraises her functioning (e.g., how rich and articulated her cognitive life is, or how much she is focused on her body and its functioning), upon the influence of the cultural environment in which she is immersed, and upon the pattern of predisposing and precipitating factors at work in that individual case.
---
Some alternative references —
A mitochondrial nexus in major depressive disorder: Integration with the psycho-immune-neuroendocrine network (2024, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease)
Association between mitochondrial DNA levels and depression: a systematic review and meta-analysis (2023, BMC Psychiatry)
Mitochondrial dysfunction: A fatal blow in depression (2023, Biomedicine & Pharmacotherapy)
Connecting Dots between Mitochondrial Dysfunction and Depression (2023, Biomolecules)
Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders (2019, Antioxidants & Redox Signaling)